Financial Health Assessment: HANNA INSTRUMENTS LIMITED

1. Financial Health Score: A

Explanation: Hanna Instruments Limited presents the picture of robust financial health, akin to a patient with excellent cardiovascular fitness and strong immunity. The company demonstrates consistent growth, exceptional liquidity, and no symptoms of financial distress. The only minor observation is a somewhat conservative approach to capital deployment – the company is holding substantial cash reserves that could potentially be utilised more dynamically. This is a "healthy but could be fitter" scenario rather than any cause for concern.

2. Key Vital Signs

💓 Liquidity Pulse (Current Ratio)

2025: 2.05:1 (Current Assets £5,157,669 ÷ Current Liabilities £2,509,988)

Diagnosis: Excellent. A current ratio above 2:1 indicates the company can comfortably meet its short-term obligations twice over. This is like having a strong heart that pumps more than enough blood to sustain the body – no risk of financial cardiac arrest here.

🫁 Quick Ratio (Acid Test)

2025: 1.78:1 (Current Assets minus Stock £4,468,933 ÷ Current Liabilities £2,509,988)

Diagnosis: Very healthy. Even excluding stock (which can be harder to convert to cash quickly), the company has nearly £1.80 for every £1 of short-term debt. The respiratory system is clear and functioning well.

🩸 Cash Vitality

2025: £3,363,306 (60.6% of total assets)

Diagnosis: Exceptionally strong but potentially over-reserved. The company holds over £3.3 million in cash – more than its entire stock and debtor balances combined. This is the financial equivalent of having tremendous stamina reserves. While this provides excellent security, it may suggest the business is not deploying capital as efficiently as it could.

📈 Net Asset Growth Trajectory

Diagnosis: Steady, reliable growth – like a patient maintaining a healthy weight with gradual improvement year on year. No dramatic spikes or crashes.

💪 Leverage Health

2025: Liabilities represent 45.2% of total assets

Diagnosis: Healthy. The company has a moderate and well-managed debt load. All liabilities appear to be current (due within one year), with no long-term debt visible. This suggests the business funds its operations from cash flow rather than relying on external borrowing – a sign of financial fitness.

🧬 Retained Earnings Progression

2024: £2,738,593 → 2025: £2,883,383 (increase of £144,790)

Diagnosis: Positive. The profit and loss reserve has grown consistently, indicating the company is profitable and retaining earnings within the business rather than distributing everything to shareholders. This builds financial resilience.

3. Diagnosis: What the Financial Data Reveals

Primary Findings

1. Exceptionally Healthy Cash Position The company's cash reserves of £3.36 million represent over 60% of total assets. This is the financial equivalent of having an immune system that's more than ready for any challenge. The business could theoretically pay off all its current liabilities and still have over £850,000 remaining in cash.

2. Conservative Capital Structure With share capital unchanged at £156,960 and no long-term debt, this is a business that has grown organically through retained profits. The three PSCs (two individual directors and one corporate entity) each holding 25-50% suggests stable, committed ownership.

3. Growing but Controlled Liabilities Current liabilities have increased from £1.93M (2023) to £2.51M (2025). However, this growth is proportionate to the growth in assets and likely reflects increased trading activity rather than financial stress. The company's working capital of £2.65M provides a substantial buffer.

4. Stock Levels Rising Stock has increased by 43.6% from £479,569 (2024) to £688,736 (2025). This warrants monitoring – is this strategic inventory build-up or a symptom of slowing sales? Without revenue data (filed under small company exemptions), this is difficult to assess definitively.

5. Tangible Asset Investment Fixed assets grew from £363,841 (2024) to £392,662 (2025), suggesting ongoing investment in the business infrastructure. This is a healthy sign – the company is not running down its asset base.

Symptoms of Note

🟢 Positive Symptoms: - Strong, consistent net asset growth - Cash reserves exceeding current liabilities - No long-term debt dependency - 37+ year trading history demonstrates resilience - Directors confirm going concern basis

🟡 Watch Symptoms: - Very high cash-to-asset ratio may indicate under-deployment of capital - Rising stock levels need to be monitored - Limited profitability disclosure due to small company filing regime

🔴 Distress Symptoms: - None identified

4. Recommendations: Prescriptions for Enhanced Financial Wellness

💊 Dose 1: Cash Deployment Review

Priority: Moderate

With over £3.3 million sitting in cash (likely earning modest interest), the company should evaluate whether some of this capital could generate higher returns through: - Strategic acquisitions or business expansion - Investment in higher-yielding instruments (within risk appetite) - Property acquisition to reduce lease costs - Enhanced shareholder returns via dividends

Medical analogy: A patient with excellent blood volume but some stagnation – get the circulation moving more dynamically.

💊 Dose 2: Stock Management Monitoring

Priority: Moderate

The 43.6% increase in stock warrants attention. Implement: - Regular stock turnover analysis - Ageing reports to identify slow-moving inventory - Just-in-time ordering where possible for fast-moving analytical instrumentation

Medical analogy: Monitor the digestive system – ensure what's being consumed is being processed efficiently, not accumulating.

💊 Dose 3: Financial Reporting Enhancement

Priority: Low (for internal benefit)

While the small companies regime limits public disclosure, internal management should track: - Gross and net profit margins - Return on capital employed - Stock turnover ratios - Debtor days

Medical analogy: Regular health screenings even when feeling well – early detection of any emerging conditions.

💊 Dose 4: Creditor Payment Optimisation

Priority: Low

With such strong cash reserves, ensure the company is taking full advantage of creditor payment terms while also potentially negotiating early payment discounts. The balance between maintaining supplier relationships and optimising cash flow should be actively managed.

💊 Dose 5: Succession and Strategic Planning

Priority: Low

As a long-established company with a stable ownership structure, ensure succession planning is in place. The PSC structure (two directors plus a US corporate entity each holding 25-50%) should have clear governance frameworks.

Prognosis: Future Financial Outlook

Outlook: Very Positive

Hanna Instruments Limited is in excellent financial health. The company has: - Demonstrated consistent growth over multiple years - Built substantial cash reserves providing exceptional resilience - Maintained a conservative but effective capital structure - Operated successfully for nearly four decades

The business is well-positioned to weather economic uncertainties and has the financial resources to pursue growth opportunities when they arise. The main risk is not financial distress but rather the opportunity cost of holding excessive cash reserves.

Risk Assessment: Low

Based on current indicators, the probability of financial distress within the next 12-24 months is very low. The company could sustain operations for an extended period even in a severe revenue downturn scenario given its cash position.